tyme technologies stock reddit

It has declined 7 over the past six months. Ad 1000 Strong Buy Stocks that Double the SP.

Why Viral Stocks Are Here To Stay

Tyme Technologies Inc a biotechnology company develops cancer metabolism-based therapies CMBTs in the United States.

. TYME Tyme Technologies Inc Stock Price and Discussion Stocktwits. USD 002 728 Market Closed-248 PE-2 Forward PE-0. Stay in touch with what people say on Twitter and Reddit about Tyme Technologies Inc.

The price has fallen in 6 of the last 10 days and is down by -3975 for this period. We are focusing on metastatic and hard-to-treat cancers for which current therapies are inadequate. Promising trial results as well as a sponsor from Georgetown University makes for very interesting potential.

Beta Notes About us FAQ. However once it is submitted for FDA approval it will be on everybodys radar and the price will reflect that. Are you thinking about adding Tyme Technologies NASDAQTYME stock to your portfolio.

TYME continues to develop a strong pipeline of cancer metabolism-based therapies for advanced cancers. These guys can atleast reach 8bn cap by that math. If their patented mode of action and TYME-19 drug can prevent COVID virus from mutating it can easily earn as much revenue as a COVID booster shot.

Morgan Stanley assigned 20 bn weight 50share to Modernas booster shot. TYME Tyme Technologies Inc. Stock Market News - Financial News - MarketWatch.

We believe that targeting cancers metabolism by disrupting protein synthesis and increasing oxidative stress has advantages over existing. The company is focused on the development and commercialization of targeted cancer therapeutics with a broad range of oncology indications for humans. The company also offers TYME-19 an.

Department of Energys National Energy Technology Laboratory NETL which has emphasized its effectiveness since the early 2000s. The technology has been recognized by the US. Find the latest Tyme Technologies Inc.

View which stocks have been most impacted by COVID-19. The company was granted additional patent claims for its product TYME-19 which can be used to treat COVID-19. SM 88 its proprietary drug candidate compound is a novel compound that has the.

Its lead candidate is the SM-88 a CMBT that is in a Phase IIIII clinical trial to treat across 15 types of cancer including pancreatic lung breast prostate sarcoma and lymphoma. I dont want to buy a stock later for 8 when it might become either 20 or 4 as soon as the FDAs decision is out. In other news insider Steve Hoffman sold 78125 shares of Tyme Technologies stock in a transaction dated Monday November 29th.

This is due to the large degree of progress that TYME stock is seeing right now. Tyme Technologies Inc is the US based clinical-stage biotechnology company. Small cap Biotech trading sub 2.

The stock has a market capitalization of 5734 million a PE ratio of -208 and a beta of 087. The stock is trading at a volume of 14m whereas it usually trades at a volume closer to 550k probably because of this catalyst coming up. The first is their SM-88 Tyme-88-Panc Phase 23 data which is expected on 1172021 at the conference.

TYME has three FDA catalysts on the line. A high-level overview of Tyme Technologies Inc. Download historical prices view past price performance and view a customizable stock chart with technical overlays and drawing tools for TYME at MarketBeat.

TYME 036 004 1121 Post-Market 001 174 12218. Is a biotech penny stock that weve discussed numerous times in the past few months. The stock recently traded at 16450 up 52.

FAQ US stock Healthcare sector Biotechnology. Currently in phase 2 of a clinical trial for their drug SM-88 a cancer metabolism-based therapy for Metastatic breast prostate andor hematological cancers. Tyme Technologies Inc NASDAQ Updated Feb 1 2022 1257 AM.

The Tyme Technologies Inc stock price fell by -503 on the last day Thursday 3rd Feb 2022 from 035 to 033. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. The stock was sold at an average price of 074.

Tyme Technologies stock was trading at 105 on March 11th 2020 when COVID-19 Coronavirus reached pandemic status according to the World Health Organization WHO. Tyme Technologies has a 1 year low of 029 and a 1 year high of 348. And has now fallen 3 days in a row.

This technology could provide Tyme an opportunity to expand its current cancer-metabolism based approach. Since then TYME shares have decreased by 660 and is now trading at 03570. We believe that TYME.

The utility industry has moved to adopt this streamlined elegant approach which improves the effectiveness of sorbent technologies in the capture of mercury emissions. During the day the stock fluctuated 1245 from a day low at 033 to a day high of 037. And that means 16 stock price until they file IND and run phase I.

TYME stock quote history news and other vital information to help you with your stock trading and investing. I like this technology enough to buy it at 3 and wait until its primed for FDA approval. Shares of Tyme Technologies soared as much as 127 on Wednesday.

Applied Dna Sciences Subsidiary Linearx Signs Agreement With Tyme Technologies For Functional Invasive Circulating Tumor Cell Assay Services In Pancreatic Cancer Trial Applied Dna Sciences

3 Biotech Penny Stocks That Are Popular On Reddit Right Now